Americans who took proton pump inhibitors, or PPIs, for four-and-a-half years or longer were 33% more likely to develop ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Pantoprazole can interact with many medications, including drugs that treat cancer, iron supplements, and HIV medicines, ...

“Tegoprazan offers an exciting new treatment option for individuals suffering from GERD, helping to address the substantial unmet need of patients not well-controlled by conventional PPI therapy,” ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the condition ...

Proton pump inhibitors (PPIs) are among the most widely used medications in the U.S., familiar to many through brand names ...

After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) </ ...

Long-term use of a common acid reflux medication may increase the risk of developing dementia by one-third, according to new research. The study found that people who used proton pump inhibitors ...